Rita J Desai

Array ( [id] => 5509144 [patent_doc_number] => 20090082351 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-26 [patent_title] => 'PESTICIDE PYRIMIDINYLOXY SUBSTITUTED PHENYLAMIDINE DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 12/063676 [patent_app_country] => US [patent_app_date] => 2006-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10732 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20090082351.pdf [firstpage_image] =>[orig_patent_app_number] => 12063676 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5194561 [patent_doc_number] => 20070083045 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-12 [patent_title] => 'Dihydroxypyrimidine carboxamide inhibitors of HIV integrase' [patent_app_type] => utility [patent_app_number] => 11/516831 [patent_app_country] => US [patent_app_date] => 2006-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 51980 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0083/20070083045.pdf [firstpage_image] =>[orig_patent_app_number] => 11516831 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5172443 [patent_doc_number] => 20070072876 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-29 [patent_title] => 'Novel pyrimidine carboxamides' [patent_app_type] => utility [patent_app_number] => 11/516549 [patent_app_country] => US [patent_app_date] => 2006-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20920 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20070072876.pdf [firstpage_image] =>[orig_patent_app_number] => 11516549 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 151715 [patent_doc_number] => 07683058 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-03-23 [patent_title] => 'Substituted pyrimidine derivatives' [patent_app_type] => utility [patent_app_number] => 11/516221 [patent_app_country] => US [patent_app_date] => 2006-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12726 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/683/07683058.pdf [firstpage_image] =>[orig_patent_app_number] => 11516221 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 567035 [patent_doc_number] => 07465750 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-12-16 [patent_title] => 'Use of GAL3 antagonist for treatment of depression and/or anxiety and compounds useful in such methods' [patent_app_type] => utility [patent_app_number] => 11/517589 [patent_app_country] => US [patent_app_date] => 2006-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 108649 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/465/07465750.pdf [firstpage_image] =>[orig_patent_app_number] => 11517589 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 121734 [patent_doc_number] => 07709468 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-04 [patent_title] => 'Imidazo based heterocycles' [patent_app_type] => utility [patent_app_number] => 11/514626 [patent_app_country] => US [patent_app_date] => 2006-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 48541 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/709/07709468.pdf [firstpage_image] =>[orig_patent_app_number] => 11514626 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5602999 [patent_doc_number] => 20060293344 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-28 [patent_title] => 'Therapeutic Compounds' [patent_app_type] => utility [patent_app_number] => 11/468319 [patent_app_country] => US [patent_app_date] => 2006-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 52696 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20060293344.pdf [firstpage_image] =>[orig_patent_app_number] => 11468319 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5149550 [patent_doc_number] => 20070049610 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-01 [patent_title] => 'Diaminopyrimidines as P2X3 and P2X2/3 modulators' [patent_app_type] => utility [patent_app_number] => 11/510015 [patent_app_country] => US [patent_app_date] => 2006-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18125 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20070049610.pdf [firstpage_image] =>[orig_patent_app_number] => 11510015 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 22475 [patent_doc_number] => 07799796 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-09-21 [patent_title] => 'Diaminopyrimidines as P2X3 and P2X2/3 modulators' [patent_app_type] => utility [patent_app_number] => 11/509890 [patent_app_country] => US [patent_app_date] => 2006-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20153 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/799/07799796.pdf [firstpage_image] =>[orig_patent_app_number] => 11509890 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5688978 [patent_doc_number] => 20060287293 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-21 [patent_title] => 'Heterocyclylalkylamines as muscarinic receptor antagonists' [patent_app_type] => utility [patent_app_number] => 11/508581 [patent_app_country] => US [patent_app_date] => 2006-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28818 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20060287293.pdf [firstpage_image] =>[orig_patent_app_number] => 11508581 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5101872 [patent_doc_number] => 20070185134 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-09 [patent_title] => 'Inhibitors of cyclin dependent kinases as anti-cancer agent' [patent_app_type] => utility [patent_app_number] => 11/507929 [patent_app_country] => US [patent_app_date] => 2006-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 16417 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0185/20070185134.pdf [firstpage_image] =>[orig_patent_app_number] => 11507929 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5609144 [patent_doc_number] => 20060270660 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-30 [patent_title] => 'Processes for preparing substituted pyrimidines' [patent_app_type] => utility [patent_app_number] => 11/500981 [patent_app_country] => US [patent_app_date] => 2006-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21631 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0270/20060270660.pdf [firstpage_image] =>[orig_patent_app_number] => 11500981 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5609113 [patent_doc_number] => 20060270629 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-30 [patent_title] => 'Methanocarba cycloalkyl nucleoside analogues' [patent_app_type] => utility [patent_app_number] => 11/500860 [patent_app_country] => US [patent_app_date] => 2006-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14260 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0270/20060270629.pdf [firstpage_image] =>[orig_patent_app_number] => 11500860 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5602989 [patent_doc_number] => 20060293334 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-28 [patent_title] => 'Nitrogen-containing heteroaryl compounds having inhibitory activity against HIV integrase' [patent_app_type] => utility [patent_app_number] => 11/500387 [patent_app_country] => US [patent_app_date] => 2006-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 83774 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20060293334.pdf [firstpage_image] =>[orig_patent_app_number] => 11500387 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 486170 [patent_doc_number] => 07217713 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-05-15 [patent_title] => 'N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase' [patent_app_type] => utility [patent_app_number] => 11/491815 [patent_app_country] => US [patent_app_date] => 2006-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 46035 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/217/07217713.pdf [firstpage_image] =>[orig_patent_app_number] => 11491815 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4813930 [patent_doc_number] => 20080194561 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-14 [patent_title] => 'Compounds' [patent_app_type] => utility [patent_app_number] => 11/996749 [patent_app_country] => US [patent_app_date] => 2006-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 55291 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20080194561.pdf [firstpage_image] =>[orig_patent_app_number] => 11996749 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 446469 [patent_doc_number] => 07253174 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-08-07 [patent_title] => 'N-heterocyclic inhibitors of TNF-α expression' [patent_app_type] => utility [patent_app_number] => 11/485075 [patent_app_country] => US [patent_app_date] => 2006-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16145 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/253/07253174.pdf [firstpage_image] =>[orig_patent_app_number] => 11485075 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 569698 [patent_doc_number] => 07462620 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-12-09 [patent_title] => 'Pyrimidinone derivatives and their use in the treatment of atherosclerosis' [patent_app_type] => utility [patent_app_number] => 11/456129 [patent_app_country] => US [patent_app_date] => 2006-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23952 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/462/07462620.pdf [firstpage_image] =>[orig_patent_app_number] => 11456129 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4534760 [patent_doc_number] => 07888367 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-02-15 [patent_title] => '1-[2′,3′ -dideoxy-3′ C-(hydroxymethyl)—beta-D-erythro-pentofuranosyl] cytosine derivatives as HIV' [patent_app_type] => utility [patent_app_number] => 11/994633 [patent_app_country] => US [patent_app_date] => 2006-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 18732 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/888/07888367.pdf [firstpage_image] =>[orig_patent_app_number] => 11994633 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6646314 [patent_doc_number] => 20100228028 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-09 [patent_title] => 'PROCESSES FOR THE MANUFACTURE OF ROSUVASTATIN AND INTERMEDIATES' [patent_app_type] => utility [patent_app_number] => 11/994925 [patent_app_country] => US [patent_app_date] => 2006-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6742 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0228/20100228028.pdf [firstpage_image] =>[orig_patent_app_number] => 11994925 [rel_patent_id] =>[rel_patent_doc_number] =>)